Under the terms of the agreement, OneMedNet will provide high-quality, de-identified, regulatory-grade healthcare data, including millions of medical imaging and associated clinical reports, with data delivery immediately. The initial agreement has a total contract value in excess of $11.5 million.

"We believe this agreement represents a significant validation of OneMedNet's unique capabilities in curating and delivering regulatory decision-grade Real-World Data at the scale and quality required for foundational AI model development. OneMedNet is uniquely positioned to deliver fully de-identified, regulatory-grade datasets through our secure, anonymized federated network of live data, enabling breakthrough AI innovation while upholding the highest standards of patient privacy and compliance. Our AI-powered iRWD™ platform, combined with our expansive provider network, makes this possible at the speed, scale, and quality that modern healthcare demands," said Aaron Green, CEO & President of OneMedNet.

"Private data is what we believe will ultimately differentiate one foundational model from another—and healthcare data is among the most private and valuable. OneMedNet's delivery platform provides live, longitudinal access to this data, with in-flight anonymization built in," stated Jeffrey Yu, MD, Chairman of OneMedNet."

This agreement is expected to build on OneMedNet’s strong commercial momentum and expanding network, which now surpasses 90 million patient journeys and 270 million clinical studies across more than 2,300 healthcare sites. This network continues to expand in scope and depth. The Company’s iRWD™ platform, enables secure, scalable delivery of multi-modal data optimized for AI training, regulatory submissions, and advanced analytics.